GASTROINTESTINAL PAIN
The GI tract is a common site of complications for the HIV/AIDS population. Opportunistic infections and HIV-related neoplasms are especially seen in patients that are either noncompliant or fail ART. When evaluating a patient with GI symptoms, the first step is to identify the level of immunodeficiency, including whether the patient is on ART or is treatment-naive. CD4 count is the best serologic marker for immune status. Those with CD4 less than 200 cells/mm
3 are at greatest risk for an opportunistic infection, with a further exponential increase at CD4 less than 100 cells/mm
3.
20 Treating the underlying problem is the primary treatment goal, although analgesia is often required especially in the acute setting.
OROPHARYNGEAL PAIN
Oral and throat pain is a very commonly seen symptom in HIV. Candidiasis of the oral cavity, which often presents as white lesions or red patches, has been estimated to affect 50% to 95% of HIV-infected patients at some point in their disease course.
21 It is one of the most common causes of oral pain, although can be asymptomatic. Oral candidiasis can also be one of the first signs of HIV infection and therefore warrants testing in a patient without a known immunodeficiency. Although most commonly caused by
Candida albicans, other
Candida species have been identified.
22 Necrotizing periodontal diseases, such as necrotizing gingivitis and ulcerative periodontitis, are also strongly associated with HIV infection.
23 Multiple viruses including Herpes simplex (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), invasive fungal species, and bacteria have been implicated in some of these cases.
ESOPHAGEAL PAIN
Although esophageal symptoms are often unrelated to HIV disease, opportunistic disease can be seen including in patients on ART. One study evaluated seropositive patients undergoing endoscopy and found an opportunistic infection in 26% of subjects on highly active antiretroviral therapy (HAART), 48% of subjects on non-ART mono- or polytherapy (no protease inhibitor), and 80% of those not on any ART.
24 In patients with upper GI symptoms (e.g., odynophagia, nausea, vomiting, hematemesis) with AIDS, an upper endoscopy results in a diagnosis in approximately 75% of patients.
25 C. albicans is the most common infectious agent affecting the esophageal tract in HIV, followed by viruses (e.g., CMV esophagitis and duodenitis, HSV esophagitis).
20
Candida esophagitis is typically seen in the setting of a CD4 count less than 200 cells/mm
3, whereas
Mycobacterium avium complex (MAC) is typically seen at when CD4 falls below 50 cells/mm
3. CMV, the most common agent causing viral esophagitis, occurs with CD4 below 100 cells/mm
3.
26 Upper endoscopy is the standard of care for upper GI symptoms, and in patients where an opportunistic infection is suspected, aggressive tissue sampling and biopsy should be done. In CMV disease, for example, multiple biopsies may increase the likelihood of diagnosis.
27 Kaposi sarcoma and lymphoma can also cause invasive disease of the esophagus, resulting in dysphagia, pain, and ulceration.
28
ABDOMINAL PAIN
Abdominal pain is another common site of pain in the HIV/AIDS population and in many cases may be associated with diarrhea. Prevalence among AIDS patients has been estimated to be 12% to 20%.
29,30,31 In addition to the common causes of abdominal pain in non-HIV patients, inflammation and direct mucosal invasion by HIV, opportunistic infections, and neoplasms are all potential causes to consider when evaluating an HIV patient.
32 The risk of opportunistic infections and neoplasms is related to the level of immunosuppression. For patients with CD4 count less than 100 cells/mm
3, for example, pathogens to consider include CMV,
Cryptosporidium, and
Microsporidium.
20 Colitis secondary to MAC infection, seen with CD4 less than 100 cells/mm
3, is increasingly rare in the ART era. This entity is mostly seen in patients that first present with late-stage HIV.
33
CMV is the most common opportunistic pathogen of the bowel, with abdominal pain often being the primary presenting symptom. In addition, small and large bowel perforation has been described with CMV ileitis.
34 Furthermore, with patients being on ART and various prophylactic antimicrobial agents, drug-induced side effects and
Clostridium difficile colitis must also be considered. Lymphoma of the GI tract can also present with abdominal pain potentially leading to intestinal obstruction or perforation. Diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma are the most common subtypes of GI lymphomas.
35
Pancreatitis is another potential cause of abdominal pain. Acute pancreatitis, often presenting with severe epigastric pain, nausea, vomiting, and fever, has an estimated yearly incidence of 0.6% to 15% in HIV-infected individuals.
36,37 Medication-induced pancreatic toxicity is considered the most common cause and has been well described with various agents including but not limited to nucleoside analogues, pentamidine, nonnucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs).
38 Furthermore, hypertriglyceridemia secondary to ART is associated with pancreatitis. Identification and discontinuation of the offending agent is critical. Treatment is otherwise supportive. Multiple opportunistic infections have also been implicated, usually in the setting of disseminated infection. These agents include CMV, MAC,
Cryptococcus,
Mycobacterium tuberculosis, and toxoplasmosis.
39 However, their incidence in causing pancreatitis is unclear given that many of these patients have also had exposure to pancreotoxic agents. In addition, pancreatitis has also been described as part of primary HIV infection with multisystem involvement.
40 Comorbid conditions such as alcohol abuse should also be considered.
Hepatobiliary symptoms, including right upper quadrant pain, are other common sites of pain. Opportunistic infections can be responsible for these cases, typically with CD4 count less than 50 cells/mm
3, suggesting this is part of a systemic disseminated disease process, with MAC being the mostly frequently seen pathogen.
33 One study reporting liver biopsies and autopsies in AIDS patients with liver disease found 38% of specimens testing positive for MAC.
41 Hepatic tuberculosis can occur earlier in the disease course. CMV and cryptosporidial infections have also been described as causes of cholecystitis and secondary sclerosing cholangitis.
42 Drug-induced liver injury (DILI) is also a common adverse effect of ART and antituberculous drugs, including but not limited to efavirenz, pyrazinamide, and isoniazid.
43 It is estimated that 8% to 23% of patients on HAART will develop DILI.
44,45
ANORECTAL
It is estimated that up to 30% of HIV-infected patients experience anorectal symptoms during the course of their illness.
46 Pain is the most common presenting symptom, affecting more than 50% of individuals.
47,48 Other common symptoms include rectal bleeding, discharge, and pruritus. Anorectal ulcers are a common cause of pain. Although most commonly idiopathic, malignancy and infectious causes including HSV, CMV, mycobacteria, and syphilis must be ruled out. It is also important to note that other sexually transmitted diseases can present in the anorectal region especially in homosexual individuals, including gonorrhea, chlamydia, and
M. tuberculosis especially in cases of nonhealing ulcers. Perirectal abscesses are also
common, typically presenting with fever and pain, and generally require surgical drainage.
Anorectal malignancy is also a major concern in HIV patients. Anal squamous intraepithelial lesions have a very high rate of occurrence in HIV-infected men that practice anal intercourse and can progress into anal cancer, although rate of progression is unknown. Risk factors include HPV subtypes 16 and 18, perirectal HSV, low CD4 count, and cigarette smoking.
46 Lymphoma and disseminated Kaposi sarcoma can also present as perianal lesions.